Riskpilot← Back to searchSign inGet full accessÅretandläkarna AB
ABActiveOrg 5590219522Tottvägen 59 BDental practice care activities · NACE 8623Est. 20152 employees
Revenue 2024
SEK 0
EBITDA margin
—
-50% vs 2023
Equity ratio
44.0%
Financial strength
Net profit 2024
SEK -1,1M
-280% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -4,5M | -50% |
| Net profit | SEK -1,1M | -280% |
| Total assets | SEK 13M | -5% |
| Equity | SEK 5,7M | -36% |
| Employees | 2 | — |
Legal name
Åretandläkarna AB
Org number
5590219522
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
31 juli 2015
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tandvård, tillverkning och utveckling av munvårdsprodukter, utbildning, äga och förvalta fast egendom samt därmed förenlig verksamhet.
Address
Tottvägen 59 B
Email
aermeskog@yahoo.co.uk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 922 | 5 262 | 0 | 0 | 0 |
| Staff expenses | — | — | −1 527 | −2 846 | −4 235 |
| EBITDA | 2 086 | 718 | −1 764 | −2 976 | −4 475 |
| Depreciation & amort. | −353 | −183 | — | −48 | −54 |
| EBIT | 1 733 | 535 | −1 764 | −3 024 | −4 528 |
| Net financials | 7 | 6 390 | 3 360 | 3 971 | 3 392 |
| Profit before tax | 1 752 | 6 930 | 1 596 | 915 | −1 103 |
| Tax | −552 | −598 | −219 | −283 | −31 |
| Net profit | 1 200 | 6 332 | 1 376 | 632 | −1 134 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 537 | 10 169 | 11 640 | 13 661 | 13 032 |
| Equity | 1 439 | 7 057 | 8 433 | 8 915 | 5 731 |
| Long-term debt | 396 | 12 | 12 | 0 | — |
| Short-term debt | 1 027 | 747 | 547 | 610 | 458 |
| Total debt | 1 423 | 759 | 559 | 610 | 458 |
EBITDA margin
-447453300.0%
This company
15.8%
Market median
-2831983011% vs market
20202024
Equity ratio
44.0%
This company
38.2%
Market median
+15% vs market
20202024
Return on equity
-19.8%
This company
18.4%
Market median
-208% vs market
20202024
Net profit margin
-113439200.0%
This company
8.1%
Market median
-1400484051% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.27×
This company
0.62×
Market median
-105% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JD Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Åretandläkarna AB 
Termino c 8829 ABBoard members of Åretandläkarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Daniel Hellström | Audit | 0 companies |
| Anne-Charlotte Cecilia Kögel Ermeskog | Deputy Board Member | 0 companies |
| Thomas Adam Ermeskog | Board of Directors | 0 companies |